ADIL
NASDAQ · Pharmaceuticals
Adial Pharmaceuticals Inc
$1.81
+0.12 (+7.10%)
Open$1.73
Previous Close$1.69
Day High$1.83
Day Low$1.70
52W High$687.50
52W Low—
Volume—
Avg Volume63.7K
Market Cap2.67M
P/E Ratio—
EPS$-16.98
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+870.7% upside
Current
$1.81
$1.81
Target
$17.57
$17.57
$13.09
$17.57 avg
$22.70
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 13.49M | 12.56M | 11.54M |
| Net Income | 2.10M | 2.52M | 1.69M |
| Profit Margin | 15.6% | 20.1% | 14.6% |
| EBITDA | 3.80M | 3.63M | 3.04M |
| Free Cash Flow | 1.15M | 1.06M | 1.39M |
| Rev Growth | +2.7% | +18.2% | +12.4% |
| Debt/Equity | 0.15 | 0.14 | 0.18 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |